市場調查報告書

研究抗體市場增長,趨勢,預測(2020-2025)

Research Antibodies Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946288
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格
研究抗體市場增長,趨勢,預測(2020-2025) Research Antibodies Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 117 Pages
簡介

預計在2020年至2025年的預測期內,研究抗體市場的複合年增長率將達到5.5%。這是由於增加了對研發的投入,行業與學術界之間的合作以及蛋白質組學和基因組學研究的增加。多項產品創新和產學合作促進了全球幹細胞和神經生物學研究的增長,加速了市場增長。此外,神經退行性疾□□病(例如多發性硬化症和帕金森氏病)的發病率增加,將增加對神經生物學研究的高質量抗體的需求,以及對蛋白質治療,個性化藥物和新藥開發的需求。預計會增加。

該報告調查了研究抗體的市場,並分析了市場概況,市場增長因素和抑制因素,市場規模以及按類型,來源,產品,應用和地區進行的預測,有關競爭格局,關鍵公司概況,市場機會等的全面信息。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 增加研發投入
    • 增加產學合作
    • 蛋白質組學和基因組學研究的興起
  • 市場約束因素
    • 研究抗體的高成本
  • 波特的五力分析

第5章市場細分

  • 按類型
    • 單克隆抗體
    • 多克隆抗體
  • 按來源
    • 兔子
    • 鼠標
    • 山羊
    • 其他
  • 按產品
    • 主要
    • 中學
  • 通過申請
    • 免疫學
    • 傳染病
    • 幹細胞
    • 腫瘤科
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Bio-Rad Laboratories, Inc.
    • Abcam plc.
    • Merck KGaA
    • Thermo Fisher Scientific
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Lonza
    • PerkinElmer Inc.
    • Cell Signaling Technology, Inc
    • Agilent Technologies

第7章市場機會和未來趨勢

目錄
Product Code: 70528

The Research Antibodies Market is expected to register a CAGR of 5.5% during the forecast period. This is attributing to increasing investment in R&D, increasing research academies and industry collaborations, and a rise in proteomics and genomics research. As research antibodies are the essential component of biopharmaceutical and pharmaceutical research for the investigation of biological processes and to know the causes of diseases these antibodies play an important role. Thus, growing stem cells and neurobiology research around the globe with several product innovations and collaboration by the companies is fueling the growth of the market. For instance, in February 2019, a company ImmunoPrecise Antibodies LTD Collaborated with Foundation of Innovative New Diagnostic (FIND) to announce research collaboration project results in which they developed rabbit monoclonal antibodies using B cells select that helps in recognizing lipoarabinomannan (LAM) and biomarker for TB. Moreover, increasing incidences of neurodegenerative diseases such as multiple sclerosis and Parkinson's diseases leading to high demand of high-quality antibodies for neurobiology research and increasing demand of protein therapeutics, personalized medicines and development of novel drug is also some more factors that are anticipated to promote the research antibodies market in forecasted period.

Key Market Trends

Primary Antibodies in Research Antibodies is Estimated to Witness a Healthy Growth in Future.

Primary Antibodies are estimated to witness a healthy growth in future which is attributed to several benefits associated with these antibodies such as higher specificity, easy availability, suitable for research. These benefits leading to high adoption among biopharmaceutical and pharmaceutical companies. Moreover, primary antibodies are used for detection, measurement, and purification of biopharmaceuticals in several applications such as ELISA, flow cytometry, western blotting, and many more. Furthermore, with several usages in the detection of biomarkers for diseases such as cancer, Parkinson's, diabetes, and Alzheimer's diseases leading to propel the segment growth.

In Addition, the growing number of biopharmaceutical research and development expenditure from past years will significantly propel the research antibodies market is forecasted period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Research Antibodies Market due to the increasing incidences of cardiovascular and blood diseases. As per The American Cancer Society, in 2018, approximately 1, 735,350 new cases of cancers were reported in the United States. This will increase the focus on cancer research and promote the demand of research antibodies market. Furthermore, rising R&D expenditure, a growing number of pharmaceutical and biopharmaceutical companies, technologically advanced research antibodies, and well-established infrastructure are also expected to fuel the Research Antibodies Market in this region.

Competitive Landscape

The Research Antibodies Market is moderately competitive and consists of several major players. Some of the companies which are currently well-known in the market are Bio-Rad Laboratories, Inc., Abcam plc., Merck KGaA, Thermo Fisher Scientific, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Lonza, PerkinElmer Inc., Cell Signaling Technology, Inc, and Agilent Technologies

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investment In R&D
    • 4.2.2 Increase In Research Academies And Industry Collaborations
    • 4.2.3 Rise In Proteomics And Genomics Research
  • 4.3 Market Restraints
    • 4.3.1 High Cost Of Research Antibodies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Monoclonal Antibodies
    • 5.1.2 Polyclonal Antibodies
  • 5.2 By Source
    • 5.2.1 Rabbit
    • 5.2.2 Mouse
    • 5.2.3 Goat
    • 5.2.4 Others
  • 5.3 By Product
    • 5.3.1 Primary
    • 5.3.2 Secondary
  • 5.4 By Application
    • 5.4.1 Immunology
    • 5.4.2 Infectious Diseases
    • 5.4.3 Stem Cells
    • 5.4.4 Oncology
    • 5.4.5 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bio-Rad Laboratories, Inc.
    • 6.1.2 Abcam plc.
    • 6.1.3 Merck KGaA
    • 6.1.4 Thermo Fisher Scientific
    • 6.1.5 Becton, Dickinson and Company
    • 6.1.6 F. Hoffmann-La Roche Ltd
    • 6.1.7 Lonza
    • 6.1.8 PerkinElmer Inc.
    • 6.1.9 Cell Signaling Technology, Inc
    • 6.1.10 Agilent Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS